New research out of the @HastingsLab !
Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis https://t.co/pMaA9knxEP
You know what's better than having one great post-doc in the @HastingsLab at @RFUniversity? Having two! Especially if they are hard working, clever, inquisitive and, most importantly, great people overall! Happy National Post Doc Week to them!
#NPAW21@proteintech
Latest research from @HastingsLab at @RFUniversity@ChicagoMedEdu using an antisense oligonucleotide as a therapeutic in a mouse model of CLN3 Batten Disease.
https://t.co/a7LPPrIJox
The latest from the @HastingsLab at @RFUniversity@ChicagoMedEdu
Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells https://t.co/IV0ObnKXpb